Abstract

In recent years, transcriptome profiling studies have identified changes in host splicing patterns caused by viral invasion, yet the functional consequences of the vast majority of these splicing events remain uncharacterized. We recently showed that the host splicing landscape changes during Rift Valley fever virus MP-12 strain (RVFV MP-12) infection of mammalian cells. Of particular interest, we observed that the host mRNA for Rio Kinase 3 (RIOK3) was alternatively spliced during infection. This kinase has been shown to be involved in pattern recognition receptor (PRR) signaling mediated by RIG-I like receptors to produce type-I interferon. Here, we characterize RIOK3 as an important component of the interferon signaling pathway during RVFV infection and demonstrate that RIOK3 mRNA expression is skewed shortly after infection to produce alternatively spliced variants that encode premature termination codons. This splicing event plays a critical role in regulation of the antiviral response. Interestingly, infection with other RNA viruses and transfection with nucleic acid-based RIG-I agonists also stimulated RIOK3 alternative splicing. Finally, we show that specifically stimulating alternative splicing of the RIOK3 transcript using a morpholino oligonucleotide reduced interferon expression. Collectively, these results indicate that RIOK3 is an important component of the mammalian interferon signaling cascade and its splicing is a potent regulatory mechanism capable of fine-tuning the host interferon response.

Highlights

  • Rift Valley Fever Virus (RVFV) is a mosquito-borne, negative sense RNA virus that belongs to the Phlebovirus genus within the Phenuiviridae family [1] that infects humans and livestock animals in Africa and the Arabian Peninsula

  • In the work presented here, we demonstrate that construct with a FLAG tag on their N-terminus

  • Transfection of stoichiometrically equivRIOK3 expressed in its canonically spliced form is important for interferon expression, an alent amounts of either full-length or X2 variant FLAG-tagged constructs into HEK293 important antiviral response

Read more

Summary

Introduction

Rift Valley Fever Virus (RVFV) is a mosquito-borne, negative sense RNA virus that belongs to the Phlebovirus genus within the Phenuiviridae family [1] that infects humans and livestock animals in Africa and the Arabian Peninsula. In humans, it can cause illness ranging from mild flu-like symptoms to hemorrhagic fever, blindness, liver disease, and death [2]. Infection by RVFV in humans may lead to increased miscarriage rates [4] It is currently categorized as a Category A pathogen and a select agent by the USA Centers for Disease Control, and no vaccines or drugs have been approved for human use in the general population. It is important to understand the molecular virology of RVFV in order to develop effective antiviral therapeutic strategies

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call